cabazitaxel fresenius kabi 20 mg/ml konzentrat zur herstellung einer infusionslösung
cabazitaxel accord injection
accord healthcare (pty) ltd - injection - each 1,0 ml solution contains cabazitaxel 20,0 mg
cabazitaxel adco infusion (parenteral)
adcock ingram critical care (pty) ltd - infusion (parenteral) - 60,0 mg per 1,5 ml - each 1,5 ml solution contains cabazitaxel 60,0 mg
jevtana
sanofi - aventis israel ltd - cabazitaxel 60 mg / 1.5 ml - concentrate for solution for infusion - cabazitaxel - in combination with prednisone for the treatment of patients with metastatic hormone refractory prostate cancer (mhrpc) previously treated with a docetaxel-based treatment regimen
jevtana
sanofi - aventis israel ltd - cabazitaxel 60 mg / 1.5 ml - concentrate for solution for infusion - cabazitaxel - in combination with prednisone for the treatment of patients with metastatic hormone refractory prostate cancer (mhrpc) previously treated with a docetaxel-based treatment regimen
jevtana concentate and solvent for solution for infusion 60 mg /1.5ml vial
bahrain pharmacy - cabazitaxel - concentate and solvent for solution for infusion - 60
jevtana 60 mg/1.5 ml concentrate for solution for injection (i.v.)
n/a; importer: sanofi aventis philippines, inc.; distributor: n/a - cabazitaxel - concentrate for solution for injection (i.v.) - 60 mg/1.5 ml
jevtana 60 mg concentrate and solvent for solution for infusion solution, concentrate
sanofi-aventis, france - cabazitaxel - solution, concentrate - 60 mg
neutaxan concentrate and solvent for solution for infusion
gensenta İlaÇ sanayi ve ticaret a.Ş, turkey - cabazitaxel - concentrate and solvent for solution for infusion - 60 mg
cabazred 60 mg/ 1.5 ml concentrate solution for i.v. infusion
onesource pharma solutions, inc.; distributor: onesource pharma solutions, inc. - cabazitaxel - concentrate solution for i.v. infusion - 60 mg/ 1.5 ml